BioCentury Publications

REALIZE SIGNIFICANT DISCOUNTS ON BIOCENTURY'S PUBLICATIONS AND DATA SOLUTIONS

BioCentury is recognized as the ESSENTIAL provider of independent, informed business intelligence. Its information platform combines analysis and data to regularly affect decisions made by bio-industry leaders and investors throughout the world.

Your benefits:

New subscribers

• Access to BioCentury's global industry analysis and data at a reduced rate for new subscribers
• Significant discounts on a one-year, single-user subscription to two weekly publications: the flagship BioCentury, the Bernstein Report on BioBusiness and the BioCentury Part II compendium of corporate, clinical and financial transactions, as well as the daily BioCentury Extra newspaper. New subscribers that are BIOTECanada Corporate A members in good standing with less than 50 employees engaged in drug/diagnostic development are eligible.
• 33% discount when you increase your BioCentury publications subscription to a 10-user group account
• 33% discount to the Data Solutions -- BioCentury Online Intelligence (BCIQ) and BioCentury Archives -- for new subscribers for one year.
• One month free trial for all publications

Current subscribers

• 33% discount when you increase your BioCentury publications subscription to a 10-user group account
• 33% discount when you upgrade your subscription to include the Data Solutions: BioCentury Online Intelligence (BCIQ) and BioCentury Archives

How it works:

Contact Subscriber Service Manager Andy Heller at BioCentury Publications, Inc.
Office: (781) 378-2011, Mobile: (617) 922-2257, Email: aheller@biocentury.com
Find out more: www.biocentury.com

BioCentury's mission is to provide value-added information and analysis for biotech and pharma companies, investors, academia and government on the strategic issues essential to the formation, development and sustainability of biopharmaceutical ventures. Our breadth of coverage includes corporate strategy, partnering, translational science, clinical data, public policy and the financing markets. All of this is supported by an in-house data warehouse that is now available to subscribers through BioCentury Online Intelligence (BCIQ).

---

BioWorld Publications

WORLDWIDE BIOTECHNOLOGY NEWS AND INFORMATION

85% off cover price for BioWorld Today and BioWorld Financial Watch for BIOTECanada Corporate A members SAVE $3000 US if you subscribe to both publications Enhance your success in the business of biotech with the newspaper of record for the industry. Delivering insider intelligence every business morning, you have access to a wide range of issues dramatically affecting the industry, including: Scientific milestones, capital sources and venture capital financing, corporate financial and stock performance, strategic alliances, agreements, sales and mergers, FDA and congressional actions. Your benefits: Exceptional savings on annual subscription fees - BioWorld Today for only US$241 - BioWorld Insight for only US$136 E-mail delivery directly to you every business morning in an easy-to-read, pdf format Weekly reports from BioWorld Financial Watch give you a complete view of the business side of biotechnology Ability to monitor collaborations, public and private financings, clinical trials and FDA submissions, stock market activity, and underwriter and venture capital portfolio performances through one source How it works: Sign up directly with BIOTECanada. Contact: BIOTECanada Janice Burke Tel: 613-230-5585 ext 223 Email: janice.burke@biotech.ca

Special Offer! BIOTECanada is pleased to offer our members the BioWorld® Executive Compensation Report 2012 for $99.00 plus HST  - Regular price of this publication is $499 US Whether you're a job-hunter, human resources executive, an investor, evaluating the competition, making a salary offer, or negotiating your own package the new 2012 Executive Compensation Report blazes the way to negotiate or evaluate compensation from a position of strength and knowledge. It lets you determine your rank among your peers; make competent hiring offers; facilitate HR with annual executive review processes; or keep abreast of market salary dynamics and more. The BioWorld Executive Compensation Report 2012 provides you with complete salary, bonus, and market capitalization data and rankings of six top-level job titles: Chief Executive Officers Chief Financial Officers Chief Operating Officers VPs of Research and Development Chief Legal Officers Heads of Business/Corporate Development To take advantage of this special offer from BIOTECanada:   Order your electronic PDF* copy of the BioWorld Executive Compensation Report 2012 for $99.00 plus HST by contacting Winnie Han at 613-230-5585 ext. 222 or by email. Please note that only credit card orders will be accepted. * You will receive an electronic PDF version of the publication BioWorld Executive Compensation Report 2012.  This offer does not apply to the print version.

---

Burrill & Company

YOUR GATEWAY TO THE GLOBAL LIFE SCIENCES INDUSTRY

Burrill & Company provides a gateway into the biotechnology and life sciences global world through its publications and events. The Media Group's goal is to provide the latest insight, intelligence and information tailored for the senior executive. Stay current and interact with the leading experts and thought leaders in your field of interest. Subscribe to the publications listed below. Access market intelligence in hard copy publications, or online.

Your benefits:

Receive 30% off the list price of Burrill & Company publications, including:

• The Burrill Stem Cell Report (4/yr), $495
• The Burrill Stem Cell Webcast/CD-Rom, $495
• The Burrill Personalized Medicine Report (4/yr), $495
• Biotech 2007, $395 +shipping
• Biotech 2008, $395 + shipping
• The Burrill Canadian Biotech News (48/yr) $475
• The Journal of Life Sciences (6/yr), $85
• The Burrill Biotechnology Intelligence Report (4/yr), $999
• Biotech 20 Year CD (1986-2006), $699

All prices in US dollars. Discounts available to BIOTECanada members only.

How it works:

Contact BIOTECanada for your membership discount code. Visit http://www.burrillandco.com/burrill/publications for a complete list of eligible publications.

Founded in 1994, Burrill & Company is a San Francisco-based global leader in life sciences with activities in Private Equity, Venture Capital, Merchant Banking and Media. The Burrill family of venture capital funds has over $950 million under management and its merchant banking business is one of the industry leaders in life sciences transactions. Burrill publishes a wide range of bio-intelligence reports including its flagship publication, the annual "State of the Industry" report. These publications provide the latest insight, intelligence and information on the life sciences industry.